Yingwei Li

905 total citations
33 papers, 707 citations indexed

About

Yingwei Li is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yingwei Li has authored 33 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Yingwei Li's work include Cancer Mechanisms and Therapy (5 papers), CAR-T cell therapy research (4 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Yingwei Li is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), CAR-T cell therapy research (4 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Yingwei Li collaborates with scholars based in China, United States and Hong Kong. Yingwei Li's co-authors include Nuo Yang, He Shen, Jianmin Zhang, Wang‐Fun Fong, Kayla E. Wilson, Guo‐Yuan Zhu, Ashley Orillion, Zhi‐Ling Yu, Beihua Kong and Beihua Kong and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Yingwei Li

27 papers receiving 702 citations

Peers

Yingwei Li
Kaushlendra Tripathi United States
Bixin Xi China
Valentina Condelli Italy
Shengjun Xiao China
Xiaotang Yu China
Qingping Jiang China
Xuxu Sun China
Suzanne Hector United States
Volker Badock Germany
Kaushlendra Tripathi United States
Yingwei Li
Citations per year, relative to Yingwei Li Yingwei Li (= 1×) peers Kaushlendra Tripathi

Countries citing papers authored by Yingwei Li

Since Specialization
Citations

This map shows the geographic impact of Yingwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingwei Li more than expected).

Fields of papers citing papers by Yingwei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingwei Li. The network helps show where Yingwei Li may publish in the future.

Co-authorship network of co-authors of Yingwei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yingwei Li. A scholar is included among the top collaborators of Yingwei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingwei Li. Yingwei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhu, Jinli, Ji Zhou, Xue Liang, et al.. (2025). Elevated CD10− neutrophils correlate with non-response and poor prognosis of CD19 CAR T-cell therapy for B-cell acute lymphoblastic leukemia. BMC Medicine. 23(1). 138–138. 2 indexed citations
4.
Zhang, Jingchao, Hao Hu, Yingwei Li, et al.. (2024). Bearing race fault detection using an optomechanical micro-resonator. Optics Express. 32(15). 26184–26184.
5.
Zhang, Xiaoxia, et al.. (2023). An Improved Multi-Scale Feature Fusion for Skin Lesion Segmentation. Applied Sciences. 13(14). 8512–8512. 13 indexed citations
6.
Pang, Ningbo, Yingwei Li, Chunliang Liu, et al.. (2023). Cyclic thrombocytopenia associated with estradiol: a case report. Hematology. 28(1). 2240140–2240140.
7.
8.
Chen, Die, Wenyan Wang, Guo‐Yuan Zhu, et al.. (2022). Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation. Biomedicine & Pharmacotherapy. 155. 113705–113705. 22 indexed citations
9.
Pan, Ying, et al.. (2021). CD4+CD25+CD127low regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia. International Immunopharmacology. 96. 107742–107742. 15 indexed citations
10.
Wang, Pengling, et al.. (2021). EPDR1, Which Is Negatively Regulated by miR-429, Suppresses Epithelial Ovarian Cancer Progression via PI3K/AKT Signaling Pathway. Frontiers in Oncology. 11. 751567–751567. 9 indexed citations
11.
Wang, Huiping, Jiakui Zhang, Qianshan Tao, et al.. (2020). Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia. Nature Communications. 11(1). 5928–5928. 48 indexed citations
12.
Qiu, Chunping, Nan Lü, Xiao Wang, et al.. (2017). Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium. Gynecologic Oncology. 147(3). 634–641. 16 indexed citations
13.
Liu, Xiaolin, Wenjing Zhang, Yuyan Wei, et al.. (2016). Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesis.. PubMed. 6(2). 249–59. 19 indexed citations
14.
Li, Yingwei, He Shen, Nuo Yang, et al.. (2015). Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis. Cell Cycle. 14(1). 146–156. 50 indexed citations
15.
Wilson, Kayla E., Yingwei Li, Nuo Yang, et al.. (2014). PTPN14 Forms a Complex with Kibra and LATS1 Proteins and Negatively Regulates the YAP Oncogenic Function. Journal of Biological Chemistry. 289(34). 23693–23700. 67 indexed citations
16.
Leung, Chung‐Hang, Daniel Shiu‐Hin Chan, Yingwei Li, Wang-Fun Fong, & Dik‐Lung Ma. (2013). Hit identification of IKKβ natural product inhibitor. BMC Pharmacology and Toxicology. 14(1). 3–3. 23 indexed citations
17.
Peng, Zhengang, Rulong Shen, Yingwei Li, et al.. (2012). Epigenetic Repression of RARRES1 Is Mediated by Methylation of a Proximal Promoter and a Loss of CTCF Binding. PLoS ONE. 7(5). e36891–e36891. 17 indexed citations
18.
Xu, Xiaofei, Zhaogang Dong, Yingwei Li, et al.. (2012). The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation. The International Journal of Biochemistry & Cell Biology. 45(3). 536–545. 35 indexed citations
19.
Zhu, Guo‐Yuan, et al.. (2011). Acylated Protopanaxadiol‐Type Ginsenosides from the Root of Panax ginseng. Chemistry & Biodiversity. 8(10). 1853–1863. 19 indexed citations
20.
Li, Yingwei, Guo‐Yuan Zhu, Xiaoling Shen, et al.. (2010). Furanodienone inhibits cell proliferation and survival by suppressing ERα signaling in human breast cancer MCF‐7 cells. Journal of Cellular Biochemistry. 112(1). 217–224. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaushlendra Tripathi Breakdown of academic impact, for papers by Bixin Xi Breakdown of academic impact, for papers by Valentina Condelli Breakdown of academic impact, for papers by Shengjun Xiao Breakdown of academic impact, for papers by Xiaotang Yu Breakdown of academic impact, for papers by Qingping Jiang Breakdown of academic impact, for papers by Xuxu Sun Breakdown of academic impact, for papers by Suzanne Hector Breakdown of academic impact, for papers by Volker Badock
Rankless by CCL
2026